Psychedellux March 5, 2021 

Psychedellux: The Psychedelic Industry News For The Week


This is Psychedellux your regular wrap-up of the psychedelic sector organization information

Psychedelic media business Delic Holdings Inc. (OTCQB: DELCF) has actually obtained mushroom package manufacturer and also media business Homestead brand names in an all-stock offer. DELIC released secondary ballot shares worth $50,000 and also 50,000 reward supply alternatives were additionally provided to Homestead owner David Tatelman, with a workout rate of $0.58. David Tatelman will certainly serve as an expert to the business.

NeonMind Biosciences Inc. (CSE: NEON) (OTC: NMBDF) introduced that they have actually submitted 4 added provisionary licenses on psilocybin preclinical information. NeonMind has a customer items department concentrating on medical mushroom instilled items, in addition to a pharmaceutical department concentrated on medicine growth of psychedelic substances.

Optimi Wellness Corp. (CSE: OPTI) shut its oversubscribed IPO and also started trading its shares last Friday on February 25, 2021 on the Canadian Stocks Exchange.

Mydecine finished its harvest of psilocybin mushrooms at a personal center in Jamaica. The very first delivery of the harvest has actually currently been gotten at Mydecine’s Canadian center, which has a Wellness Canada Set up 1 Supplier’s Permit affixed to it.

Novamind Inc. (OTC: NVMDF) reported its monetary second-quarter outcomes for the 3 months finished December 31, 2020. The business had income of $1.2 million largely made up of individual solutions from the centers in Utah. The business claimed it was a 47% rise over the very first monetary quarter finishing September 30 th, 2020.

Ehave, Inc. (OTC Pink: EHVVF) declared a license for a hallmark on its KetaDASH brand. The business additionally submitted its application to uplist its shares on the OTCQB market.

Cybin Inc. (OTCQB: CLXPF) uplisted from the Pink Sheets to the OTCQB Endeavor Market with the icon “CLXPF”.

Article Sights:

READ  High Trend Crushes 4th Quarter, 166% Rise in Income




The declarations made worrying these items have not been reviewed by the Cuisines and also Medicine Management. The effectiveness of those product has actually not been validated by FDA-approved evaluation. These goods are generally not suggested to detect, manage, solution, or prevent any kind of disease. All information located right below will certainly not be suggested as a different option to or various from information from wellness treatment professionals. Please look for the suggestions of your wellness treatment experienced concerning prospective communications or various achievable concerns previously than using any kind of item. The Federal Cuisines, Medicine and also Appeal Act needs this exploration.